DexCom (DXCM) free cash flow was $1.1B in FY2025 (+71% YoY). The tables below show the complete quarterly and annual free cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Free Cash Flow
Fiscal Year
Free Cash Flow
YoY
2025
$1.1B
+71%
2024
$631M
+23%
2023
$512M
+68%
2022
$305M
+472%
2021
$53M
-81%
2020
$277M
+106%
2019
$134M
+140%
2018
$56M
+116%
2017
$26M
+5100%
2016
$500,000
-97%
2015
$16M
+112%
2014
$7M
+235%
2013
-$6M
+87%
2012
-$43M
-12%
2011
-$38M
+23%
2010
-$50M
-17%
2009
-$42M
Recent Quarterly Free Cash Flow
Quarter
Free Cash Flow
Q1 2026
$449M
Q4 2025
$192M
Q3 2025
$579M
Q2 2025
$209M
Q1 2025
$97M
Q4 2024
$177M
Q3 2024
$88M
Q2 2024
$213M
Q1 2024
$152M
Q4 2023
$81M
Q3 2023
$219M
Q2 2023
$131M
Source: DXCM on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.